Immunologic monitoring in adults with acute lymphoblastic leukemia (Q35190698)

7 August 2017

1 reference

title

Immunologic monitoring in adults with acute lymphoblastic leukemia (English)

1 reference

7 August 2017

lymphoblastic leukemia

1 reference

inferred from title

author name string

María-Belén Vidriales

series ordinal

1

1 reference

7 August 2017

Alberto Orfao

series ordinal

2

1 reference

7 August 2017

Jesús F San-Miguel

series ordinal

3

1 reference

7 August 2017

language of work or name

1 reference

1 September 2003

1 reference

7 August 2017

Current Oncology Reports

1 reference

7 August 2017

5

1 reference

7 August 2017

5

1 reference

7 August 2017

413-418

1 reference

https://scigraph.springernature.com/pub.10.1007/s11912-003-0028-4

7 August 2017

0 references

cites work

Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: method and significance

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11912-003-0028-4

Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions

21 January 2018

1 reference

12 December 2020

Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia

1 reference

12 December 2020

Prognostic significance of fluorescence intensity of surface marker expression in childhood B-precursor acute lymphoblastic leukemia. A Pediatric Oncology Group Study

1 reference

12 December 2020

Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes

1 reference

12 December 2020

Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia

1 reference

12 December 2020

Quantification of minimal residual disease in patients with BCR-ABL-positive acute lymphoblastic leukaemia using quantitative competitive polymerase chain reaction

1 reference

12 December 2020

Minimal residual disease in leukaemia patients

1 reference

12 December 2020

Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation

1 reference

12 December 2020

Outcome prediction by immunophenotypic minimal residual disease detection in adult T-cell acute lymphoblastic leukaemia

1 reference

12 December 2020

Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia.

1 reference

12 December 2020

Myeloid markers in adult acute lymphocytic leukemia. Correlations with patient and disease characteristics and with prognosis

1 reference

12 December 2020

Immunophenotypic patterns and cytogenetic anomalies in acute non-lymphoblastic leukemia subtypes: a prospective study of 432 patients

1 reference

12 December 2020

Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia

1 reference

12 December 2020

Slow disappearance of peripheral blood blasts is an adverse prognostic factor in childhood T cell acute lymphoblastic leukemia: a Pediatric Oncology Group study

1 reference

12 December 2020

Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia

1 reference

12 December 2020

Detection of minimal residual disease in acute leukemia

1 reference

12 December 2020

Molecular analysis of an unusual rearrangement between chromosomes 4 and 11 in adult pre-B-cell acute lymphoblastic leukemia

1 reference

12 December 2020

Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance

1 reference

12 December 2020

Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer--Childhood Leukemia Cooperative Group

1 reference

12 December 2020

BIOMED-1 concerted action report: flow cytometric immunophenotyping of precursor B-ALL with standardized triple-stainings

1 reference

12 December 2020

Immunophenotypic differences between putative hematopoietic stem cells and childhood B-cell precursor acute lymphoblastic leukemia cells.

1 reference

12 December 2020

Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia

1 reference

12 December 2020

Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia

1 reference

12 December 2020

Recent approaches in acute lymphoblastic leukemia in adults

1 reference

12 December 2020

Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia.

1 reference

12 December 2020

Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection

1 reference

12 December 2020

A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection

1 reference

12 December 2020

Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period

1 reference

12 December 2020

Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation

1 reference

12 December 2020

Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response

1 reference

12 December 2020

Persistence of lymphoblasts in bone marrow on day 15 and days 22 to 25 of remission induction predicts a dismal treatment outcome in children with acute lymphoblastic leukemia.

1 reference

12 December 2020

Immunophenotypical detection of minimal residual disease in acute leukemia.

1 reference

12 December 2020

Detection of abnormalities in B-cell differentiation pattern is a useful tool to predict relapse in precursor-B-ALL

1 reference

12 December 2020

Increased expression of myeloid antigen markers in adult acute lymphoblastic leukaemia patients: diagnostic and prognostic implications

1 reference

12 December 2020

Flow cytometry and allele-specific oligonucleotide PCR are equally effective in detection of minimal residual disease in ALL

1 reference

12 December 2020

Advances in the immunological monitoring of childhood acute lymphoblastic leukaemia

1 reference

12 December 2020

Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group experience.

1 reference

12 December 2020

Shift of aberrant antigen expression at relapse or at treatment failure in acute leukemia

1 reference

12 December 2020

Management of adult acute lymphoblastic leukemia: moving toward a risk-adapted approach

1 reference

12 December 2020

Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.

1 reference

12 December 2020

Sensitivity of combined DNA/immunophenotype flow cytometry for the detection of low levels of aneuploid lymphoblastic leukemia cells in bone marrow

1 reference

12 December 2020

Shifts in expression of immunological cell markers in relapsed acute leukemia

1 reference

12 December 2020

Immunophenotype of adult and childhood acute lymphoblastic leukemia: changes at first relapse and clinico-prognostic implications

1 reference

12 December 2020

Early response to chemotherapy as a prognostic factor in childhood acute lymphoblastic leukaemia: a methodological review

1 reference

12 December 2020

Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia.

1 reference

12 December 2020

Detection of minimal residual disease in acute leukemia by flow cytometry

1 reference

12 December 2020

BIOMED-1 Concerted Action report: Flow cytometric characterization of CD7+ cell subsets in normal bone marrow as a basis for the diagnosis and follow-up of T cell acute lymphoblastic leukemia (T-ALL)

1 reference

12 December 2020

Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL

1 reference

12 December 2020

10.1007/S11912-003-0028-4

Identifiers

DOI

1 reference

7 August 2017

1 reference